REPOCEUTICALS A/S
CVR 36494433 · Public limited company (A/S) · Active · Low risk
REPOCEUTICALS A/S is a Public limited company (A/S), founded on , based in Hørsholm. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 11 annual reports have been published. CEO: Torsten Bjørn.
Bankruptcy risk for REPOCEUTICALS A/S
0.9%
probability of bankruptcy within 12 months
Low risk
0.6 × the average (1.41%) · higher risk than 70% of active Danish companies
Lowest riskHighest risk
Increases the risk
CEO's previous bankruptcies1 · bankruptcy rate 14.2%1.6×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×
Reduces the risk
Reporting classReporting class C, mellemstor virksomhed · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 36494433
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (11 years)
- Address
- Slotsmarken 12, 1. th
2970 Hørsholm - Municipality
- Hørsholm
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 896k
- Employees
- 1 (2018)
- Auditor
- Grant Thornton, Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 11 |
| Missing annual report | No |
| Negative equity | – |
| Equity ratio | – |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 58 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Auditor's report on audited financial statements · Grant Thornton Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 159 | ||
| 1 Jan 2024 – 31 Dec 2024 | 179 | ||
| 1 Jan 2023 – 31 Dec 2023 | 172 | ||
| 1 Jan 2022 – 31 Dec 2022 | 153 | ||
| 1 Jan 2021 – 31 Dec 2021 | 153 | ||
| 1 Jan 2020 – 31 Dec 2020 | 183 | ||
| 1 Jan 2019 – 31 Dec 2019 | 171 | ||
| 1 Jan 2018 – 31 Dec 2018 | 168 | ||
| 1 Jan 2017 – 31 Dec 2017 | 158 | ||
| 1 Jan 2016 – 31 Dec 2016 | 160 | ||
| 16 Jan 2015 – 31 Dec 2015 | 172 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Torsten Bjørn | Current | |
| CEO | Henrik Lasse Lindblad | ||
| Board | Christian Vinding Thomsen | Current | |
| Board | Charlotte Pahl | Current | |
| Board | Henrik Bulskov | Current | |
| Board | Troels Peter Troelsen | ||
| Board | Preben Møllegaard Grundtvig | ||
| Board | Henrik Bulskov | ||
| Board | Sigbjørn Georg Nielsen Kjærgård | ||
| Board | Nete Søgaard Poulsen | ||
| Board | Charlotte Pahl | ||
| Board | Troels Peter Troelsen | ||
| Board | Sigbjørn Georg Nielsen Kjærgård | ||
| Board | Troels Peter Troelsen | ||
| Owner (5%) | CLINICURO ApS | Current | |
| Owner (10%) | NIELS ERIK JESPERSEN HOLDING ApS | Current | |
| Owner (5%) | PM Group Holding ApS | Current | |
| Owner (10%) | Anpartsselskabet af 11.11.2019 | Current | |
| Owner (10%) | Beier Holding ApS | Current | |
| Owner (15%) | DMZ HOLDING ApS | Current | |
| Owner (25%) | JARO HOLDING ApS | ||
| Owner (15%) | ASBA CONSULTING ApS | ||
| Owner (5%) | VULKAN INVEST ApS | ||
| Owner (10%) | CLINICURO ApS | ||
| Owner (33%) | MLL-001 ApS | ||
| Owner (25%) | MLL-001 ApS | ||
| Owner (50%) | JARO HOLDING ApS | ||
| Owner (25%) | JARO HOLDING ApS | ||
| Owner (5%) | SAX FINANS ApS | ||
| Owner (10%) | TT 1919 ApS | ||
| Owner (15%) | CLINICURO ApS | ||
| Owner (10%) | CLINICURO ApS | ||
| Owner (10%) | Støckler Invest ApS | ||
| Owner (5%) | BREGNERØDVEJ AUTO ApS | ||
| Owner (25%) | Morten Peter Friis | ||
| Owner (20%) | Scandinavian Shares Holding AB | ||
| Owner (15%) | MLL-001 ApS | ||
| Owner (5%) | LMJ Trading & Import ApS | ||
| Owner (33%) | SAX FINANS ApS | ||
| Owner (5%) | TT 1919 ApS | ||
| Owner (5%) | Beier Holding ApS | ||
| Owner (5%) | NIELS ERIK JESPERSEN HOLDING ApS | ||
| Owner (10%) | SAX FINANS ApS | ||
| Owner (20%) | MLL-001 ApS | ||
| Owner (5%) | PM Group Holding ApS | ||
| Owner (10%) | TT 1919 ApS | ||
| Owner (5%) | KJELDSBJERGGAARD ApS | ||
| Owner (5%) | TT 1919 ApS | ||
| Owner (10%) | PM Group Holding ApS | ||
| Owner (5%) | Beier Holding ApS | ||
| Owner (10%) | MLL-001 ApS | ||
| Owner (5%) | FINANSMANAGEMENT ApS | ||
| Owner (5%) | DMZ HOLDING ApS | ||
| Owner (10%) | DMZ HOLDING ApS | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | Current | |
| Founder | MLL-001 ApS | Current |
The CEOs' other companies
Torsten Bjørn – 21 other companies, of which 2 bankrupt
- NATURAL MEDICO TECH ApS Bankrupt 26 Nov 2010
- VICH 3955 ApS Bankrupt 17 Oct 1996
- AKI Therapeutics A/S Active
- AQUA-WALL DANMARK A/S Fusioneret
- BIOPORTO DIAGNOSTICS A/S Active
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- Geysir Holding ApS Active
- Geysir Invest ApS Active
- NORDIC BIOTECH HOLDING ApS Active
- Nordic Pharma Lab ApS Active
- Nordic Science Group ApS Active
- REPONEX PHARMACEUTICALS A/S Active
- REPOS PHARMA ApS Opløst
- SAX FINANS ApS Active
- SCHWANEBECK VERWALTUNG ZWEI ApS Opløst
- SPONSOR SUPPORT ApS Compulsorily dissolved
- SPRINGE/GESTORF VERWALTUNG ApS Active
- Serenova A/S Opløst
- VICTOR & FABIAN ApS Compulsorily dissolved
- VULKAN INVEST ApS Active
Henrik Lasse Lindblad – 50 other companies, of which 8 bankrupt
- ADVANCED MEDICO TECHNOLOGY A/S Bankrupt 7 Jul 1998
- ApS KBIL 38 NR. 1597 Bankrupt 13 Jun 1995
- CAPINORDIC BANK A/S Bankrupt 11 Feb 2010
- CSV INVEST ApS Bankrupt 22 Apr 2020
- Green Energy Circle ApS Bankrupt 4 Dec 2025
- NATURAL MEDICO TECH ApS Bankrupt 26 Nov 2010
- ROVSING APPLICATIONS ApS Bankrupt 20 Jul 2018
- SAMSON BØRSMÆGLERSELSKAB A/S Bankrupt 21 Jun 1995
- AKTIE & VALUTAINVEST ApS Active
- AKTIESELSKABET TRITON Compulsorily dissolved
- AQUA-WALL DANMARK A/S Fusioneret
- ApS KBUS 17 NR. 4807 Opløst
- Aurea Kapital ApS Active
- BBH Invest ApS Active
- BIOPHARMA HOLDING ApS Opløst
- BIOPORTO A/S Active
- BIOPORTO DIAGNOSTICS A/S Active
- Balder HPG A/S Active
- Balder Plaza A/S Active
- Bios I Pharma ApS Active
- CAPINORDIC CAPITAL FONDSMÆGLERSELSKAB A/S Opløst
- CB1 ApS Active
- COLEXON SOLAR INVEST A/S Opløst
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- DKA FINANS ApS Opløst
- DKA INVEST ApS Opløst
- Dansk Biogødning A/S Active
- EUROPEAN PROPERTY MANAGEMENT A/S Opløst
- Erestas ApS Active
Address history (0 moves)
| Slotsmarken 12, 1. th, 2970 Hørsholm |
Former names
| REPOCEUTICALS A/S | – now |
| REPOCEUTICALS ApS | – |
Employees per year
Other companies at the same address
- CVIP ApS Bankrupt
- CVIP HOLDING ApS Bankrupt
- HI AF 26/11-2010 A/S Bankrupt
- Liquid Wind Denmark ApS Bankrupt
- A/S CRYSTINOL Fusioneret
- AKI Therapeutics A/S Active
- ApS KBUS 17 NR. 4807 Opløst
- ApS KBUS 38 NR. 1027 Opløst
- Aurea Kapital ApS Active
- BIOPHARMA HOLDING ApS Opløst
- BLANKAMI ApS Opløst
- CAMBRIDGE TECHNOLOGY PARTNERS A/S Opløst
- DKA ADMINISTRATION ApS Opløst
- DKA CONSULT ApS Opløst
- DKA EJENDOMME ApS Opløst
- DKA FINANS ApS Opløst
- DKA INVEST ApS Opløst
- EXPANDIT DEVELOPMENT ApS Active
- EXPANDIT HOLDING A/S Active
- EXPANDIT INTERNATIONAL A/S Active
- EXPANDIT MOBILE ApS Active
- EXPANDIT UTILITIES ApS Opløst
- Erestas ApS Active
- FACET 4 ApS Compulsorily dissolved
- FINANSMANAGEMENT 2 ApS Opløst
Similar companies in Hørsholm
- PeriOp Innovations ApS Hørsholm
- Nordic Science Group ApS Hørsholm
- Nordic Pharma Lab ApS Hørsholm
- Afyx Therapeutics A/S Hørsholm
- AKI Therapeutics A/S Hørsholm
- CONRIG PHARMA ApS Vedbæk
- REPONEX PHARMACEUTICALS A/S Hørsholm
- RB af 31-5-2018 ApS Hørsholm
- Netto Medicin IVS Rungsted Kyst
- Footprint Pharma ApS Hørsholm
- REPOS PHARMA ApS Hørsholm
Questions and answers about REPOCEUTICALS A/S
Has REPOCEUTICALS A/S gone bankrupt?
No, REPOCEUTICALS A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of REPOCEUTICALS A/S?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of REPOCEUTICALS A/S?
Torsten Bjørn is the CEO of REPOCEUTICALS A/S.
Who is the auditor of REPOCEUTICALS A/S?
REPOCEUTICALS A/S most recently used Grant Thornton, Godkendt Revisionspartnerselskab.
When was REPOCEUTICALS A/S founded?
REPOCEUTICALS A/S was founded on 16 January 2015.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.